OSI Pharmaceuticals Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
402.62 Mil |
| Income |
414.05 Mil |
| Net Profit Margin |
102.84% |
| Return on Equity |
93.22% |
| Debt/Equity Ratio |
0.56 |
|
| Revenue/Share |
6.49 |
| Earnings/Share |
6.34 |
| Book Value/Share |
11.72 |
| Dividend Rate |
0.00 |
| Payout Ratio |
0.00% |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 93.7 | 90.7 | 77.5 |
| 2nd Qtr | 99.1 | 95.7 | 78.9 |
| 3rd Qtr | 111.4 | 94.6 | 100.4 |
| 4th Qtr | NA | 98.4 | 84.3 |
| Total | 304.2 | 379.4 | 341.0 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | $0.28 | $0.46 | $0.12 |
| 2nd Qtr | $0.29 | $0.39 | $0.34 |
| 3rd Qtr | $0.30 | $0.90 | $0.51 |
| 4th Qtr | NA | $6.29 | $0.18 |
| Total | $0.87 | $8.04 | $1.15 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | -96% | 156% | --- |
| 2nd Qtr | 4% | -15% | 183% |
| 3rd Qtr | 3% | 131% | 50% |
| 4th Qtr | NA | 599% | -65% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -39% | 283% |
| 2nd Qtr | -26% | 15% |
| 3rd Qtr | -67% | 76% |
| 4th Qtr | NA | 3,394% |
advertisement
Recent News